Unilabs strengthens its presence in Madrid
Unilabs announced today that its wholly-owned subsidiary Unilabs Espa?a has signed an agreement to buy 100% of the shares of Labipath, a leading clinical laboratory in Madrid. Labipath had revenues in excess of Euros 1.6 million in 2004, and maintains 7 phlebotomy centers in Madrid receiving an average of 300 patients per day. Labipath also provides laboratory services to two major Madrid hospitals: Clínica Belen and Hospital Venerable Orden Tercera de San Francisco de Asís.
Most read news
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.